申请人:G. D. Searle & Co.
公开号:US05130330A1
公开(公告)日:1992-07-14
Certain nitrogen-containing cyclohetero cycloalkylaminoaryl compounds are described for treatment of CNS disorders such as cerebral ischemia, psychotic disorders and convulsions. Compounds of particular interest are of the formula ##STR1## wherein R.sup.1 is selected from hydrido, loweralkyl, cycloalkylalkyl of four to six carbon atoms, and loweralkenylloweralkyl; wherein each of R.sup.2 and R.sup.3 is independently selected from hydrido and loweralkyl; wherein each of R.sup.4 through R.sup.7, R.sup.10 and R.sup.11 is independently selected from hydrido, hydroxy, loweralkyl, benzyl, phenoxy, benzyloxy and haloloweralkyl; wherein n is a number selected from four through six; wherein p is a number selected from zero through four; wherein q is a number selected from three through five; wherein A is selected from phenyl, naphthyl and thienyl; wherein any of the foregoing A groups can be further substituted with one or more substituents independently selected from hydrido, hydroxy, loweralkyl, loweralkoxy, halo, haloloweralkyl, amino, monoloweralkylamino and diloweralkylamino; or a pharmaceutically acceptable salt thereof.
描述了用于治疗中枢神经系统疾病如脑缺血、精神疾病和癫痫的某些含氮环杂环烷基氨基芳基化合物。特别感兴趣的化合物的结构如下:其中R.sup.1从氢、较低烷基、四至六个碳原子的环烷基烷基和较低烯基较低烷基中选择;其中R.sup.2和R.sup.3各自独立地选择自氢和较低烷基;其中R.sup.4到R.sup.7、R.sup.10和R.sup.11各自独立地选择自氢、羟基、较低烷基、苄基、苯氧基、苄氧基和卤代较低烷基;其中n是从四到六选择的数字;其中p是从零到四选择的数字;其中q是从三到五选择的数字;其中A从苯基、萘基和噻吩基中选择;其中上述任何A基可以进一步用一个或多个取代基独立选择自氢、羟基、较低烷基、较低烷氧基、卤、卤代较低烷基、氨基、单烷基氨基和双烷基氨基进行取代;或其药学上可接受的盐。